Patients' Beliefs About Their Cardiovascular Medications After Acute Coronary Syndrome

被引：0
|
作者：
Zhou, L. [1 ]
Wang, E. H. Z. [1 ,2 ]
Chua, D. [1 ,2 ]
Loewen, P. [1 ]
Barry, A. [1 ,3 ]
机构：
[1] Univ British Columbia, Fac Pharmaceut Sci, Vancouver, BC, Canada
[2] St Pauls Hosp, Lower Mainland Pharm Serv, Vancouver, BC, Canada
[3] Jim Pattison Outpatient Care & Surg Ctr, Lower Mainland Pharm Serv, Surrey, BC, Canada
来源：
CANADIAN JOURNAL OF HOSPITAL PHARMACY | 2023年 / 76卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：152 / 153
页数：2
相关论文
共 50 条
  • [21] Development and validation of a cardiovascular risk score for patients in the community after acute coronary syndrome
    Poppe, Katrina K.
    Doughty, Rob N.
    Wells, Susan Mary
    Wu, Billy
    Earle, Nikki J.
    Richards, A. Mark
    Troughton, Richard W.
    Jackson, Rod
    Kerr, Andrew J.
    HEART, 2020, 106 (07) : 506 - 511
  • [22] SNP-Treatment Interactions of Cardiovascular Medications and Risk of Acute Coronary Syndrome Recurrence
    Yin, Peng
    Jorgensen, Andrea
    Morris, Andrew
    Turner, Richard
    Fitzgerald, Richard
    Stables, Rod
    Hanson, Anita
    Pirmohamed, Munir
    GENETIC EPIDEMIOLOGY, 2016, 40 (07) : 672 - 672
  • [23] Effects of patients' beliefs about medications on non-adherence to chronic medications
    Phatak, HM
    Thomas, J
    VALUE IN HEALTH, 2005, 8 (03) : 237 - 237
  • [24] Use of secondary preventive medications after the first attack of acute coronary syndrome
    Salomaa, Veikko
    Paakkonen, Rauni
    Hamalainen, Helena
    Niemi, Marja
    Klaukka, Timo
    EUROPEAN JOURNAL OF CARDIOVASCULAR PREVENTION & REHABILITATION, 2007, 14 (03): : 386 - 391
  • [25] Characteristics of the knowledge of patients after acute coronary syndrome about cardiovascular risk factors as an element of secondary prevention -gender differences.
    Jankowska-Polanska, B.
    Grzebieluch, J.
    Felinczak, A.
    EUROPEAN JOURNAL OF CARDIOVASCULAR NURSING, 2020, 19 (1_SUPPL) : S46 - S46
  • [26] Beliefs About Medications in IBD
    Lars-Petter, Jelsness-Jorgensen
    Tomm, Bernklev
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2018, 113 : S8 - S8
  • [27] The use of cardiovascular medications in patients with coronary artery disease before and after percutaneous coronary intervention
    Tangsucharit, P.
    Samkaew, T.
    Laowachirasuwan, C.
    Jantaruechai, S.
    RESEARCH IN SOCIAL & ADMINISTRATIVE PHARMACY, 2014, 10 (05): : E56 - E56
  • [28] Metabolic syndrome and the risk of adverse cardiovascular events after an acute coronary syndrome
    Cavallari, Ilaria
    Cannon, Christopher P.
    Braunwald, Eugene
    Goodrich, Erica L.
    Im, KyungAh
    Lukas, Mary Ann
    O'Donoghue, Michelle L.
    EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY, 2018, 25 (08) : 830 - 838
  • [29] Long-term cardiovascular outcomes after percutaneous coronary interventions in patients with acute coronary syndrome and cancer
    Ma, Y.
    Cheng, Y. J.
    Ohene, B. E.
    Yang, L. X.
    Zhou, Y. J.
    EUROPEAN HEART JOURNAL, 2019, 40 : 287 - 287
  • [30] Risk Factors for Death or Cardiovascular Events after Acute Coronary Syndrome in Patients with Myeloproliferative Neoplasms
    Leiva, Orly
    Jenkins, Andrew
    Rosovsky, Rachel P.
    Leaf, Rebecca K.
    Goodarzi, Katayoon
    Hobbs, Gabriela
    HEMATOLOGY REPORTS, 2023, 15 (02) : 398 - 404
12345